ASCO Pleased to See Cancer Research Prioritized in President ...

President Biden unveiled his proposed Fiscal Year 2025 federal budget on March 11 that prioritizes cancer research and strengthens the U.S. ...

ASCO Commends President Biden for Prioritizing Cancer Research ...

In his last State of the Union address this term, President Joe Biden emphasized critical policy priorities that the Association for ...

ASCO Urges White House to Prioritize Cancer Drug Shortages and ...

The Association for Clinical Oncology (ASCO) is urging President Biden to keep cancer care and research among his top national priorities on ...

Cancer Care Providers Urge President Biden to Make Health Care a ...

The Association for Clinical Oncology (ASCO) is calling on President Biden to continue to prioritize access to high-quality, ...

ASCO President Lists Progress Made in Cancer, Highlighting ...

Chicago, IL—The theme of the 2017 American Society of Clinical Oncology (ASCO) annual meeting was “Making a Difference in Cancer Care With You.

ASCO Applauds President Biden's Leadership in Relaunching The ...

President John F. Kennedy's historic speech that inspired our nation and an entire generation of Americans to achieve manned space ...

ASCO President Defines Annual Goals of Cancer Organization

On the heels of its annual meeting, ASCO president Robin Zon outlines the organization's goals, including the use of AI in cancer treatment.

President's FY25 Budget Prioritizes Funding for Cancer Research ...

The American Cancer Society Cancer Action Network (ACS CAN) is pleased to see President Biden's continued focus on and dedication to ...

Oncologists Applaud State of the Union's Focus on Ending Cancer ...

Julie R. Gralow, MD, FACP, FASCO, Chief Medical Officer and Executive Vice President of ASCO and the Association for Clinical Oncology, ...

ASCO Applauds Senate for Prioritizing Cancer Research in FY 2025

The Association for Clinical Oncology (ASCO) is applauding the Senate Appropriations Committee for its bipartisan support of federal cancer research.

Clinical Cancer Advances 2021: ASCO's Report on Progress ...

A growing number of targeted therapies are offering extended survival for more patients with difficult-to-treat cancers. ASCO Research ...

On One Year Anniversary of Reignited Cancer Moonshot, Biden ...

One year ago, President Joe Biden and First Lady Jill Biden reignited the Cancer Moonshot, setting an ambitious, achievable goal: to reduce ...

Ensuring Equity in Precision Cancer Care - YouTube

Moderated by ASCO President Lori J. Pierce, MD, FASTRO, FASCO, and Sybil Green, JD, RPh, MHA, ASCO Diversity and Inclusion Officer, ...

ASCO Member Testifies Before Congress Urging Significant ...

Dr. Brian Persing, a medical oncologist and hematologist in Mobile, Alabama and member of the Association of Clinical Oncology (ASCO), ...

ASCO Applauds Bold Recommendations From Cancer Moonshot ...

“We applaud the Blue Ribbon Panel for its work and the National Cancer Institute's (NCI's) National Cancer Advisory Board for convening the ...

Cancer groups expect bold moves reminiscent of the 2016 ...

Jed Manocherian, Act for NIH: President Biden is determined to advance cancer research, promote the sharing of cancer research, and implement ...

Cancer Doctors Applaud State of the Union's Focus on Ending ...

ASCO applauds President Biden's focus on 'ending cancer as we know it' during the State of the Union address. We continue to urge the ...

New ASCO president aims to improve access, return 'humanity' to ...

Robin T. Zon, MD, FACP, FASCO, prepares to begin her term as ASCO president, she hopes to leverage one of the profession's greatest resources — ...

2024 President's Address: “The Art and Science of Cancer Care

At the 2024 ASCO Annual Meeting, 2023-2024 ASCO president Dr. Lynn M. Schuchter reflected on the art of medicine and the critical importance ...

Prioritize COVID Vaccines for Cancer Patients | Letter to Biden ...

Led by the AACR, more than 130 organizations call on the Biden administration to prioritize cancer patients in the distribution of the COVID-19 vaccine.